Arcturus Therapeutics Holdings Inc
General ticker "ARCT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $466.8M
Arcturus Therapeutics Holdings Inc does not follow the US Stock Market performance with the rate: -27.5%.
Estimated limits based on current volatility of 4.8%: low 14.50$, high 15.97$
Factors to consider:
- Current price 23.9% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [21.68$, 44.13$]
- 2024-12-30 to 2025-12-30 estimated range: [21.14$, 43.30$]
Financial Metrics affecting the ARCT estimates:
- Negative: Non-GAAP EPS, $ of -2.03 <= 0.10
- Negative: Operating profit margin, % of -33.14 <= 1.03
- Negative: Operating cash flow per share per price, % of -2.49 <= 2.35
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term ARCT quotes
Long-term ARCT plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $12.36MM | $206.00MM | $157.75MM |
Operating Expenses | $215.21MM | $193.82MM | $235.95MM |
Operating Income | $-202.85MM | $12.18MM | $-78.20MM |
Non-Operating Income | $-0.82MM | $-1.53MM | $50.31MM |
Interest Expense | $2.67MM | $0.42MM | $0.77MM |
R&D Expense | $173.76MM | $147.75MM | $192.13MM |
Income(Loss) | $-203.67MM | $10.64MM | $-27.89MM |
Taxes | $0.00MM | $1.29MM | $1.83MM |
Profit(Loss) | $-203.67MM | $9.35MM | $-29.73MM |
Stockholders Equity | $228.21MM | $270.31MM | $278.51MM |
Inventory | $0.00MM | $0.00MM | $0.00MM |
Assets | $392.81MM | $450.39MM | $429.40MM |
Operating Cash Flow | $-135.04MM | $31.99MM | $-18.10MM |
Capital expenditure | $3.41MM | $7.73MM | $2.90MM |
Investing Cash Flow | $-3.41MM | $-7.73MM | $-2.90MM |
Financing Cash Flow | $48.02MM | $-2.86MM | $-24.09MM |
Earnings Per Share* | $-7.86 | $0.35 | $-1.12 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.